Women with a history of adverse pregnancy complications are at significantly higher risk of developing heart disease but can reduce their risk by maintaining optimal heart health after pregnancy, according to preliminary research to be presented at the American Heart Association’s Epidemiology and Prevention│Lifestyle and Cardiometabolic Scientific Sessions 2024, March 18- 21, in Chicago.
Merck highlights subcutaneous demand even as Keytruda sales soar
Merck said Keytruda sales jumped 21% to $6.6 billion in the fourth quarter of the year, driven by new approvals in earlier-stage indications for breast
February 2, 2024